News
-
-
PRESS RELEASE
Amoéba announces the success of its capital increase of 14 M EUR to support its industrial and commercial deployment
Amoéba (FR0011051598 - ALMIB) successfully raises €14 million through a capital increase to support industrial and commercial expansion. Investors incl. Nice & Green show confidence. New shares to be admitted on Euronext Growth market of Euronext Paris -
-
PRESS RELEASE
Amoéba launches a capital increase open to all to support its industrial and commercial deployment
Amoéba, a greentech company, announces a capital increase of up to €14 million to support industrial and commercial growth in biocontrol and cosmetics. Key partners and subscription commitments outlined -
-
PRESS RELEASE
Amoéba signs an agreement with Metron Technology, a subsidiary of Oriental Beauty Valley (OBV), a key player in the cosmetics industry in China
Amoéba signs agreement with Metron Technology, subsidiary of Oriental Beauty Valley, for cosmetic ingredient in China. Accelerating entry into second largest cosmetics market -
-
-
-
PRESS RELEASE
Amoéba takes another decisive step forward with the final approval of its biocontrol active substance by the European Commission
Amoéba receives final approval from European Commission for its biocontrol active substance, AXPERA, after successful validation process confirming low-risk profile